Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
October 22, 2013

Biomarker Trajectories: Molecular Entities and Their Progression as Biomarkers

This report based on more than 92,000 publications illustrates biomarker trends over time.

Biomarker Trajectories: Molecular Entities and Their Progression as Biomarkers

Biomarkers over time. [Dmitry Sunagatov - Fotolia.com]

  • The focus of this GEN Market & Tech Analysis report is to present some of our most recent analysis of publications trends across a number of biomarker classes with respect to time over the past five years as a way to map the trajectory of these molecular species.

    Specifically, we present here selected examples from the following classes:

    • Traditional biomarkers
    • microRNAs
    • Long noncoding RNAs
    • Epigenetics modifications

    This temporal analysis seeks to map the evolution of a particular marker—one at a time—and therefore provides a granular approach to understanding specific trends as they relate to specific molecular entities and drivers for their utilization/adoption in research as well as in clinical practice.

    Highlights of this GEN Report:

    • A comparative analysis of the complete set of biomarker-focused publications from the scientific literature illustrates the publication trends over time and enables a picture to be sketched of the expansion or contraction of a particular class of biomarkers.
    • Our analysis has been based on more than 92,000 publications which we’ve sorted and segmented into various classes based on the context in which they appear in the publication record.
    • We have compared various molecular species in this report excerpted from our comprehensive database of all of the common markers that have been described.
    • We’ve also compared in our analysis the molecular lesions that are the subject of companion diagnostics development and association with specific therapeutics in defined disease classes.
    • Finally, our database allows the interrogation of a particular molecular entity in order to ask whether any association[s] have been documented with specific disease classes, in this manner identifying “virgin territory” for potential IP protection.

    CLICK HERE to download the PDF report.

Related content